Steven M. Paul - 01 Apr 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Steven M. Paul
Issuer symbol
ALNY
Transactions as of
01 Apr 2022
Net transactions value
-$2,390,421
Form type
4
Filing time
05 Apr 2022, 16:05:01 UTC
Previous filing
17 Feb 2022
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $169,950 +15,000 +1500% $11.33* 16,000 01 Apr 2022 Direct F1
transaction ALNY Common Stock Sale $42,008 -253 -1.6% $166.04 15,747 01 Apr 2022 Direct F1, F2
transaction ALNY Common Stock Sale $835,965 -4,948 -31% $168.95 10,799 01 Apr 2022 Direct F1, F3
transaction ALNY Common Stock Sale $826,827 -4,872 -45% $169.71 5,927 01 Apr 2022 Direct F1, F4
transaction ALNY Common Stock Sale $211,383 -1,235 -21% $171.16 4,692 01 Apr 2022 Direct F1, F5
transaction ALNY Common Stock Sale $246,791 -1,434 -31% $172.10 3,258 01 Apr 2022 Direct F1, F6
transaction ALNY Common Stock Sale $111,105 -642 -20% $173.06 2,616 01 Apr 2022 Direct F1, F7
transaction ALNY Common Stock Sale $15,690 -90 -3.4% $174.33 2,526 01 Apr 2022 Direct F1
transaction ALNY Common Stock Sale $92,844 -526 -21% $176.51 2,000 01 Apr 2022 Direct F1, F8
transaction ALNY Common Stock Sale $146,504 -825 -41% $177.58 1,175 01 Apr 2022 Direct F1, F9
transaction ALNY Common Stock Sale $31,255 -175 -15% $178.60 1,000 01 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Non-Qualified Stock Option (right to buy) Options Exercise $0 -15,000 -100% $0.000000* 0 01 Apr 2022 Common Stock 15,000 $11.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2021. The 15,000 options exercised and sold by the reporting person were due to expire on June 21, 2022.
F2 Sale prices ranged from $165.91 to $166.41.
F3 Sale prices ranged from $168.30 to $169.30.
F4 Sale prices ranged from $169.32 to $170.28.
F5 Sale prices ranged from $170.70 to $171.63.
F6 Sale prices ranged from $171.75 to $172.73.
F7 Sale prices ranged from $172.83 to $173.37.
F8 Sale prices ranged from $176.04 to $176.88.
F9 Sale prices ranged from $177.12 to $178.00.